» Subscribe Today!
More of what you want to know.
The Daily News
X

Forgot your password?
Skip Navigation LinksHome >
VOL. 133 | NO. 100 | Friday, May 18, 2018

FDA Names Drugmakers Accused of Blocking Cheaper Generics

By LINDA A. JOHNSON, AP Medical Writer

Print | Front Page | Email this story | Comments ()

TRENTON, N.J. (AP) – U.S. drug regulators are publicizing information on brand-name drugmakers that use what government officials call "gaming tactics" to block cheaper copycat versions.

The Food and Drug Administration's new webpage names the makers of more than 50 brand-name drugs, some carrying six-figure annual price tags, who are under scrutiny. The agency also lists how many inquiries it has received from generic drugmakers who say they are having trouble getting access to the brand-name drugs.

Generic drug companies generally require 1,000 to 1,500 units, such as pills, of a brand-name drug to create much-cheaper drugs with identical active ingredients and effects. The FDA says brand-name drugmakers sometimes refuse to sell generic companies drugs that may need extra safety monitoring or bar drug wholesalers from selling other medicines to generic drugmakers.

Copyright 2018 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Sign-Up For Our Free Email Edition
Get the news first with our daily email


 
Blog News, Training & Events
RECORD TOTALS DAY WEEK YEAR
PROPERTY SALES 143 381 16,005
MORTGAGES 148 432 18,480
FORECLOSURE NOTICES 0 34 2,439
BUILDING PERMITS 0 452 32,966
BANKRUPTCIES 59 237 10,250
BUSINESS LICENSES 37 110 5,288
UTILITY CONNECTIONS 0 92 6,240
MARRIAGE LICENSES 16 79 3,492

Weekly Edition

Issues | About

The Memphis News: Business, politics, and the public interest.